Contract services utilizing GLP and GMP regulations.
Qbiogene, through its wholly owned subsidiary Excell Biotech Ltd.,
now offers clinical grade recombinant adenoviral vectors in our
current good manufacturing (cGMP) production facility.
For more information, please visit Excell Biotech Ltd. at:
Our commitment
Dedicated to tailoring solutions to each customer and every individual
project, our experienced staff will take care of the detailed planning,
documentation, manufacture and testing to provide the highest level
of service and satisfaction.
Quality Assurance
Quality System Rules are used for adenoviral vectors manufactured
for clinical trial and therapeutic biologics intended for human
use. The quality system regulation includes requirements related
to the methods used in product manufacturing, packaging, labeling,
storage, and contains facilities and process controls.
Capabilities
Qbiogene’s cGMP facility has a proven record of achievements
in cGMP productions for the diagnostic, pharmaceutical and animal
industries worldwide.
Services Include:
Pilot Project Production of adenoviral vectors under GLP grade
for pre-clinical studies
